WATCH LIVE Dec. 15 (EST) - PST/PDT (Pacific Daylight, GMT-7)

WATCH LIVE Dec. 15 (EST) 8:45am - 9:15am30 mins

OmniClic: Transgenic Chickens Producing Human Antibodies for Bispecifics

Phil Leighton, PhD - Director of Molecular Biology, Ligand Pharmaceuticals
Katie Ching, PhD - Research Investigator, Ligand Pharmaceuticals, Inc.

WATCH LIVE Dec. 15 (EST) 9:30am - 10:00am30 mins

Scientific Briefing 1

Stainless Steel to Single-Use: How To Adapt To The Changing Landscape in SUT

Ryan MacDonald - Sr. Engineer Manufacturing Quality Sciences, Avid Bioservices

WATCH LIVE Dec. 15 (EST) 9:30am - 10:00am30 mins

Scientific Briefing 2

High Throughput Charge Variant Screening of Therapeutic Proteins

Guangnan Meng, PhD - Product Leader, Microfluidics, PerkinElmer, Inc.

LIVE Moderated Panel Discussions with Audience Q&A - To prepare for these discussions/Q&As, attendees should view the presentations from these sessions in the Watch On-Demand Sessions Tab in advance - SEE ON-DEMAND TALKS DEC. 15 TAB

WATCH LIVE Dec. 15 (EST) 10:15am - 11:00am45 mins

Sourcing Disease-specific Human Antibodies from Patient Repertoires

Kerry Chester, PhD - Professor of Molecular Medicine, UCL Cancer Institute
Jennifer Cochran, Ph.D. - Professor and Department Chair of Bioengineering, Stanford University
Nina Luning Prak, M.D., Ph.D. - Professor of Pathology and Laboratory Medicine, University of Pennsylvania Perelman School
Leslie Goo, Ph.D. - Assistant Professor Vaccine and Infectious Disease, Fred Hutchinson Cancer Research Center
Sarav Rajan, Ph.D. - Senior Scientist, AstraZeneca
Scott Boyd, M.D, Ph.D. - Associate Professor, Stanford University Medical Center

WATCH LIVE Dec. 15 (EST) 10:15am - 11:00am45 mins

Transforming Therapeutic Targets

James Ernst, Ph.D. - Senior Director, Head of Development Sciences, Xencor
Greg Lazar, Ph.D. - Director and Senior Scientist, Antibody Engineering, Genentech
Oliver Hills, Ph.D. - VP Drug Discovery/Lead Optimization, Apogenix AG
Maria Jure-Kunkel, Ph.D. - Head of Late Stage Oncology Translational Medicine, Genmab
Michael Curran, Ph.D. - Associate Professor, Department of Immunology, The UT MD Anderson Cancer Center
Thomas Schürpf, Ph.D. - Associate Director, Discovery Biology, Scholar Rock
Denise Faustman, M.D., Ph.D. - Associate Professor of Medicine, Harvard Medical School

WATCH LIVE Dec. 15 (EST) 11:15am - 12:00pm45 mins

Keynote Introduction by Session Chair and KEYNOTE PRESENTATION with Live Q&A: Engineering Bispecific Antibodies as Therapeutics: Utilizing Intrinsic Heavy/Light Chain Pairing Preferences and Mitigating High Viscosity

Paul Carter, PhD - Genentech Fellow, Department of Antibody Engineering, Genentech, Inc.
Andreas Plückthun, PhD - Professor and Director, University of Zurich

LIVE Moderated Panel Discussions with Audience Q&A - To prepare for these discussions/Q&As, attendees should view the presentations from these sessions in the Watch On-Demand Sessions Tab in advance

WATCH LIVE Dec. 15 (EST) 12:15pm - 1:00pm45 mins

FcR and Antibody Effector Functions

Falk Nimmerjahn, PhD - Professor, University of Erlangen-Nuremberg
Galit Alter, Ph.D. - Professor of Medicine, Harvard Medical School and Group Leader, Ragon Institute of MGH, MIT and Harvard
Tanya Mayadas, Ph.D. - Professor of Pathology, Center for Excellence in V, Brigham and Women's Hospital
Stephen Beers, PhD - Professor of Immunology and Immunotherapy, Antibody and Vaccine Group, Centre for Cancer Immunology, University of Southampton
Faith Harris - Senior R&D Specialist, Regeneron
Björn Frendéus, Ph.D. - Chief Scientific Officer, BioInvent International AB
Anna Park, Ph.D. - Distinguished Scientist, Head of Protein Engineering, Sanofi

WATCH LIVE Dec. 15 (EST) 12:15pm - 1:00pm45 mins

Developments in ADC Technology

Sally Ward, PhD - Professor and Director, University of Southampton
Matthew Levengood, Ph.D. - Principal Scientist, Protein Sciences, Seattle Genetics
David Thurston - Professor Drug Discovery, Kings College London
Christian Rohlff - Chief Executive Officer & Founder, Oxford BioTherapeutics
Mahendra Deonarain, PhD - Chief Executive and Science Officer, Antikor Biopharma Ltd
Peter J. Hudson, PhD - Chief Scientific Officer, Avipep Pty Ltd.

WATCH LIVE Dec. 15 (EST) 1:00pm - 2:00pm60 mins

FREE TIME: Visit the Solution Provider Showcase - Virtual Hubs, View Posters, On-Demand Sessions or Schedule 1:1 Meetings with other Attendees

WATCH LIVE Dec. 15 (EST) 2:00pm - 2:30pm30 mins

Scientific Briefing 1

High-content multiparametric antibody screening for specificity and function with AbTheneum(TM)

Chun-Nan Chen, PhD - CEO, Single Cell Technology, Inc.

WATCH LIVE Dec. 15 (EST) 2:00pm - 2:30pm30 mins

Scientific Briefing 2

GenScript's Cutting-Edge Technologies for Precision Engineering And COVID-19

Marinella Sandros - Senior Global Product Manager, GenScript

WATCH LIVE Dec. 15 (EST) 2:30pm - 2:45pm15 mins

Scientific Briefing 1

View our 10-Minute Hot Topic Presentations

WATCH LIVE Dec. 15 (EST) 2:30pm - 2:45pm15 mins

Scientific Briefing 2

View our 10-Minute Hot Topic Presentations

WATCH LIVE Dec. 15 (EST) 2:45pm - 3:15pm30 mins

Scientific Briefing 1

Combining Directed Evolution and Droplet Microfluidics to Increase Titers and Reduce Cell Line Development Timelines

Nicholas Barber, PhD - Principal Scientist, FUJIFILM Diosynth Biotechnologies

WATCH LIVE Dec. 15 (EST) 2:45pm - 3:15pm30 mins

Scientific Briefing 2

Rapid Antibody Discovery against Difficult Targets using Berkeley Lights Beacon®

Patricia Odermatt, PhD - Research Scientist, Single B Cell, Genovac Antibody Discovery

LIVE Moderated Panel Discussion with Audience Q&A - To prepare for this discussion/Q&A, attendees should view the presentations from this session in the Watch On-Demand Sessions Tab in advance

WATCH LIVE Dec. 15 (EST) 3:30pm - 4:15pm45 mins

Inducible Activation of Antibodies to Enhance Therapeutic Index

Paul Carter, PhD - Genentech Fellow, Department of Antibody Engineering, Genentech, Inc.
Marcia Belvin, Ph.D. - SVP, Research, CytomX Therapeutics
William Boyle, Ph.D - Chief of Translation Medicine, BioAtla
Tim Clackson, Ph.D. - President & EVP R&D, Xilio Therapeutics
Volker Schellenberger, Ph.D. - President and CTO, Amunix Pharmaceuticals
William Winston, Ph.D. - Vice President, Research, Werewolf Therapeutics
Julie Su - Principal Scientist, Bristol-Myers Squibb
Mika Kamata-Sakurai, Ph.D. - Senior Director, Translational Research Division, Chugai Pharmaceutical Co., Ltd.

WATCH LIVE Dec. 15 (EST) 4:30pm - 5:15pm45 mins

Special Session of The Antibody Society: Antibodies to Watch in 2021

Janice Reichert, Ph.D. - Editor-in-Chief / Executive Director / Managing Director, mAbs / The Antibody Society / Reichert Biotechnology Consulting LLC

WATCH LIVE Dec. 15 (EST) 5:15pm - 5:20pm5 mins

Close of Day 2

SAVE UP TO $700 IF YOU BOOK BEFORE JULY 17 2021

SAVE UP TO $700 IF YOU BOOK BEFORE JULY 17 2021

WATCH LIVE Dec. 15 (EST) - PST/PDT (Pacific Daylight, GMT-7)

WATCH LIVE Dec. 15 (EST) - PST/PDT (Pacific Daylight, GMT-7)

Get the latest news.
As it happens

SAVE UP TO $700 IF YOU BOOK BEFORE JULY 17 2021

SAVE UP TO $700 IF YOU BOOK BEFORE JULY 17 2021

WATCH LIVE Dec. 15 (EST) - PST/PDT (Pacific Daylight, GMT-7)

WATCH LIVE Dec. 15 (EST) - PST/PDT (Pacific Daylight, GMT-7)

Get the latest news.As it happens

Get the latest news.
As it happens